Interim Report January – September 2018
Hemfosa’s extraordinary general meeting on 13 September 2018 resolved in accordance with the proposal of the Board of Directors to distribute all shares in the subsidiary Nyfosa AB to Hemfosa’s ordinary shareholders. Accordingly, the information in this report refers to Hemfosa excluding Nyfosa (Continuing operations), unless otherwise stated. Nyfosa is recognized in this report as Operations to be distributed to shareholders in accordance with IFRS 5 and IFRIC 17. This means that Nyfosa’s profit for the period is recognized on a separate line in the consolidated statement of profit/loss and